Systems Biology Analysis of Human Erythropoiesis

人类红细胞生成的系统生物学分析

基本信息

  • 批准号:
    8734667
  • 负责人:
  • 金额:
    $ 71.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Erythropoiesis is a fundamental process in vertebrate animals and has long served as a paradigm for molecular investigations of developmental regulation. It has been well established that a small number of transcription factors, also known as master regulators, play an essential role in the maintenance of cell-identity and/or regulate the cell differentiation process. However, it is not fully elucidated how they work in combination with each other or various cofactors, particularly at different developmental stages. Since there are at least a thousand transcriptional regulators in mammals, the number of possible combinations is astronomical. Using experimental methods alone to dissect such complexity remains a daunting task as it demands prohibitively high cost and labor. To overcome this challenge, we propose a systems biology approach to be carried out by a team of experienced experimental and computational biologists. Using human primary erythroid precursor cells as the model system, we will generate extensive experimental data by genomic, epigenomic, and transcriptomic profiling, develop data-integrative and predictive computational methods, and perturb the systems by disrupting the normal regulatory activities. Our preliminary work has identified important regulatory network differences between adult and fetal erythroid precursors and suggested that collaboration between master regulators and cofactors plays an important role in driving developmental stage-specific transcriptional changes through acting upon enhancer elements. This will be extended by focusing on the following specific aims: (1) Predict and validate the developmental stage-specific gene regulatory networks in human primary erythroid precursors by integrating genomic and epigenomic data-types; (2) Perturb the gene regulatory networks using molecular and genetic experiments and further integrate such information to refine our network model; (3) Characterize the role of genetic variants influencing chromatin state, gene expression, and erythroid traits. In the end our results will greatly expand our current mechanistic understanding of combinatorial control in establishing cell-type and developmental stage-specificity and provide functional insights into erythroid trait- associated genetic variants.
描述(由申请人提供):红细胞生成是脊椎动物的基本过程,长期以来一直作为发育调控分子研究的范例。已经充分确定,少数转录因子(也称为主调节因子)在维持细胞身份和/或调节细胞分化过程中起重要作用。然而,还没有完全阐明它们如何相互结合或与各种辅因子结合,特别是在不同的发育阶段。由于哺乳动物中至少有1000种转录调节因子,因此可能的组合数量是天文数字。单独使用实验方法来剖析这种复杂性仍然是一项艰巨的任务,因为它需要高得惊人的成本和劳动力。为了克服这一挑战,我们提出了一个系统生物学的方法进行了一个团队的经验丰富的实验和计算生物学家。以人原代红系前体细胞为模型系统,我们将通过基因组、表观基因组和转录组分析产生大量的实验数据,开发数据整合和预测计算方法,并通过破坏正常的调控活动来干扰系统。我们的初步工作已经确定了成人和胎儿红系前体细胞之间重要的调控网络差异,并表明主调节因子和辅因子之间的合作通过作用于增强子元件在驱动发育阶段特异性转录变化中起着重要作用。本研究的主要目的是:(1)通过整合基因组和表观基因组数据类型,预测和验证人类初级红系前体细胞发育阶段特异性基因调控网络;(2)利用分子和遗传学实验干扰基因调控网络,并进一步整合这些信息,完善我们的网络模型;(3)表征影响染色质状态、基因表达和红系性状的遗传变异的作用。最后,我们的结果将大大扩展我们目前在建立细胞类型和发育阶段特异性方面对组合控制的机制理解,并提供对红系性状相关遗传变异的功能性见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STUART H ORKIN其他文献

STUART H ORKIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STUART H ORKIN', 18)}}的其他基金

DEGRADATION OF BCL11A PROTEIN FOR HbF REACTIVATION
BCL11A 蛋白降解以促进 HbF 重新激活
  • 批准号:
    10733620
  • 财政年份:
    2023
  • 资助金额:
    $ 71.24万
  • 项目类别:
A CENTER OF MOLECULAR HEMATOLOGY
分子血液学中心
  • 批准号:
    10201083
  • 财政年份:
    2016
  • 资助金额:
    $ 71.24万
  • 项目类别:
A CENTER OF MOLECULAR HEMATOLOGY
分子血液学中心
  • 批准号:
    9750694
  • 财政年份:
    2016
  • 资助金额:
    $ 71.24万
  • 项目类别:
A CENTER OF MOLECULAR HEMATOLOGY
分子血液学中心
  • 批准号:
    9987187
  • 财政年份:
    2016
  • 资助金额:
    $ 71.24万
  • 项目类别:
Systems Biology Analysis of Human Erythropoiesis
人类红细胞生成的系统生物学分析
  • 批准号:
    9066186
  • 财政年份:
    2014
  • 资助金额:
    $ 71.24万
  • 项目类别:
Systems Biology Analysis of Human Erythropoiesis
人类红细胞生成的系统生物学分析
  • 批准号:
    9294127
  • 财政年份:
    2014
  • 资助金额:
    $ 71.24万
  • 项目类别:
Systems Biology Analysis of Human Erythropoiesis
人类红细胞生成的系统生物学分析
  • 批准号:
    8919832
  • 财政年份:
    2014
  • 资助金额:
    $ 71.24万
  • 项目类别:
Hemoglobin Switching: Genetics to Translation
血红蛋白转换:遗传学到翻译
  • 批准号:
    8205184
  • 财政年份:
    2011
  • 资助金额:
    $ 71.24万
  • 项目类别:
Research Training in Pediatric Oncology
儿科肿瘤学研究培训
  • 批准号:
    8794154
  • 财政年份:
    2009
  • 资助金额:
    $ 71.24万
  • 项目类别:
Research Training in Pediatric Oncology
儿科肿瘤学研究培训
  • 批准号:
    8288591
  • 财政年份:
    2009
  • 资助金额:
    $ 71.24万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 71.24万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 71.24万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 71.24万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 71.24万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 71.24万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 71.24万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 71.24万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 71.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 71.24万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 71.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了